BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8194094)

  • 1. [The effect of chronic administration of ethanol on experimental adriamycin nephropathy].
    Tesar V; Zima T; Poledne R; Stejskalová A; Stípek S; Tĕmínová J
    Cas Lek Cesk; 1994 May; 133(9):268-71. PubMed ID: 8194094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of chronic ethanol administration on adriamycin-induced nephrotic syndrome in rats.
    Tesar V; Zima T; Poledne R; Stejskalová A; Stípek S; Tĕmínová J
    Alcohol Alcohol; 1995 Jan; 30(1):47-53. PubMed ID: 7748275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of lovastatin on the development of adriamycin nephropathy in rats].
    Tesar V; Zima T; Poledne R; Stejskalová A; Tĕmínová J; Stípek S
    Sb Lek; 1995; 96(1):35-42. PubMed ID: 8711364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of pefloxacin on nephrotic syndrome in experimental adriamycin nephropathy].
    Zima T; Tesar V; Rychlík I; Nĕmecek K; Poledne R; Stejskalová A; Tĕmínová J; Stípek S; Merta M
    Cas Lek Cesk; 1995 Oct; 134(20):658-60. PubMed ID: 7489582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of losartan and enalapril on urinary excretion of 8-isoprostane in experimental nephrotic syndrome].
    Tesar V; Zima T; Jirsa M; Crkovská J; Stípek S; Vernerová Z; Seráková M
    Cas Lek Cesk; 1999 Oct; 138(18):560-4. PubMed ID: 10596472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of deferoxamine, N-acetylcysteine and selenium treatments in rats with Adriamycin-induced nephrotic syndrome.
    Bulucu F; Oktenli C; Kenar L; Ocal R; Koc B; Inal V; Yamanel L; Yaman H; Sanisoglu YS; Aydin A
    J Nephrol; 2008; 21(4):576-83. PubMed ID: 18651549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enalapril prevents fatty liver in nephrotic rats.
    Toblli JE; Ferder L; Stella I; Angerosa M; Inserra F
    J Nephrol; 2002; 15(4):358-67. PubMed ID: 12243364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular dysfunction in adriamycin nephrosis: different effects of adriamycin exposure and nephrosis.
    Ulu N; Buikema H; van Gilst WH; Navis G
    Nephrol Dial Transplant; 2008 Jun; 23(6):1854-60. PubMed ID: 18218687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glomerular sclerosis in nephrotic rats. Comparison of the long-term effects of adriamycin and aminonucleoside.
    Grond J; Weening JJ; Elema JD
    Lab Invest; 1984 Sep; 51(3):277-85. PubMed ID: 6471809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ICRF-187 (dexrazoxan) protects from adriamycin-induced nephrotic syndrome in rats.
    Zima T; Tesar V; Crkovská J; Stejskalová A; Pláteník J; Temínová J; Nemecek K; Janebová M; Stípek S
    Nephrol Dial Transplant; 1998 Aug; 13(8):1975-9. PubMed ID: 9719150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of high-lipid diet on glomerular mesangial matrix in adriamycin-induced nephrotic rats].
    Song H; Li X; Wei M; Zhu C
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Oct; 22(5):471-5. PubMed ID: 12903432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of pigment epithelium-derived factor (PEDF) reduces proteinuria by suppressing decreased nephrin and increased VEGF expression in the glomeruli of adriamycin-injected rats.
    Fujimura T; Yamagishi S; Ueda S; Fukami K; Shibata R; Matsumoto Y; Kaida Y; Hayashida A; Koike K; Matsui T; Nakamura K; Okuda S
    Nephrol Dial Transplant; 2009 May; 24(5):1397-406. PubMed ID: 19042927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome.
    Koshikawa M; Mukoyama M; Mori K; Suganami T; Sawai K; Yoshioka T; Nagae T; Yokoi H; Kawachi H; Shimizu F; Sugawara A; Nakao K
    J Am Soc Nephrol; 2005 Sep; 16(9):2690-701. PubMed ID: 15987752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes of glomerular fixed anionic charge sites in adriamycin nephrosis in rats.
    Wang Z; Wang ZG; Liu Z
    Chin Med J (Engl); 1991 Feb; 104(2):128-31. PubMed ID: 1714805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma lipoproteins and renal apolipoproteins in rats with chronic adriamycin nephrosis.
    Joles JA; van Tol A; Jansen EH; Koomans HA; Rabelink TJ; Grond J; van Goor H
    Nephrol Dial Transplant; 1993; 8(9):831-8. PubMed ID: 8255516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroids and Adriamycin nephrosis.
    Bertani T; Remuzzi G; Rocchi G; Delaini F; Sacchi G; Falchetti M; Donati MB
    Appl Pathol; 1984; 2(1):32-8. PubMed ID: 6525317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renoprotective effects of sirolimus in non-immune initiated focal segmental glomerulosclerosis.
    Rangan GK; Coombes JD
    Nephrol Dial Transplant; 2007 Aug; 22(8):2175-82. PubMed ID: 17550925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Messenger RNA expressions of vasopressin system and aquaporin-2 in adriamycin-induced nephrotic rats and effects of astragalus membranaceus.
    Ma J; Fan S; Chen J; Gu Y; Lin S
    Chin Med J (Engl); 1999 Dec; 112(12):1068-72. PubMed ID: 11721440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adriamycin-induced chronic proteinuria: a structural and functional study.
    O'Donnell MP; Michels L; Kasiske B; Raij L; Keane WF
    J Lab Clin Med; 1985 Jul; 106(1):62-7. PubMed ID: 4009023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of high-lipid diet on glomerular mesangial matrix in adriamycin-induced nephrotic rats.
    Song H; Li X; Wei M; Zhu C
    Chin Med Sci J; 2002 Sep; 17(3):134-9. PubMed ID: 12901534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.